-
Juno Therapeutics On a Roll in Q3 with Celgene's Cash and Lift of Clinical Hold
Post on 11/14/16
-
Delcath Announces Third Quarter Financial Results
Post on 11/13/16
-
Pfizer Announces Major Expansion of Humanitarian Assistance Program
Post on 11/13/16
-
MetLife Recognized as Military Friendly Employer Fifth Year in a Row
Post on 11/11/16
-
Why Allergan, Horizon Pharma plc, and Pfizer All Spiked Wednesday
Post on 11/11/16
-
Better Buy: Gilead Sciences Inc. vs. Pfizer Inc.
Post on 11/10/16
-
Trump's Win Is Causing a Tremendous Sell-Off in Hospital Stocks
Post on 11/10/16
-
Is a Donald Trump Presidency a Black Swan Event for Pharma Stocks?
Post on 11/10/16
-
Alexion Provides Update on Form 10-Q Filing
Post on 11/9/16
-
Eagle Pharmaceuticals Reports Third Quarter 2016 Results
Post on 11/9/16
-
Bristol-Myers Squibb and Infinity Pharmaceuticals Announce Clinical Collaboration
Post on 11/9/16
-
Better Buy: Amgen Inc. vs. Johnson & Johnson
Post on 11/9/16
-
Regeneron Pharmaceuticals, Inc. Dropped 14.3% in October -- Here's Why
Post on 11/9/16
-
Cognizant Technology Sees Profit Growth Ahead
Post on 11/8/16
-
Here's Why Amicus Therapeutics, Inc. Soared As Much As 20% Despite an Earnings Miss
Post on 11/8/16
-
Is Pfizer Inc.'s 6.4% Drop in October the Beginning of a Long Downtrend?
Post on 11/8/16
-
Celldex Therapeutics, Inc. Watches Its Cash in Q3, Ready to Expand
Post on 11/8/16
-
SAFE-BioPharma Partnership Named Winner of HHS "Move Health Data Forward Challenge"
Post on 11/7/16
-
Takeda and Koneksa Health Announce Strategic Collaboration
Post on 11/7/16
-
Progenics Announces $50 Million RELISTOR Royalty-Backed Financing
Post on 11/7/16
-
3 Things You Really Need to Know About Regeneron Pharmaceuticals' Q3 Results
Post on 11/7/16
-
PAVmed Partners with Leading Academic Institutions
Post on 11/6/16
-
Novartis Takes Aim at Pfizer
Post on 11/4/16
-
Amerigroup New Jersey Joins National Comprehensive Primary Care Plus Initiative
Post on 11/3/16
-
Pfizer Delivers Another Solid Quarter Of Organic Growth
Post on 11/3/16
New York
